High-dose methotrexate in patients with primary central nervous system lymphoma: does drug exposure really matter?

被引：2
|
作者：
Joerger, Markus [1 ]
Huitema, A. D. R. [2 ]
Illerhaus, G. [3 ]
Ferreri, A. J. M. [4 ]
机构：
[1] Cantonal Hosp, Dept Hematol & Oncol, CH-9007 St Gallen, Switzerland
[2] Slotervaart Hosp, Netherlands Canc Inst, Dept Pharm & Pharmacol, Amsterdam, Netherlands
[3] Univ Med Ctr, Dept Hematol & Oncol, Freiburg, Germany
[4] Ist Sci San Raffaele, Unit Lymphoid Malignancies, Dept Oncohematol, I-20132 Milan, Italy
来源：
LEUKEMIA & LYMPHOMA | 2011年 / 52卷 / 10期
关键词：
UNDER-THE-CURVE; TRIAL;
D O I：
10.3109/10428194.2011.580027
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1825 / 1827
页数：3
相关论文
共 50 条
  • [1] Rituximab with high-dose methotrexate in primary central nervous system lymphoma
    Kansara, Roopesh
    Shenkier, Tamara N.
    Connors, Joseph M.
    Sehn, Laurie H.
    Savage, Kerry J.
    Gerrie, Alina S.
    Villa, Diego
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (12) : 1149 - 1154
  • [2] Management of Patients With Primary Central Nervous System Lymphoma Treated With High-Dose Methotrexate
    Warnick, Elizabeth
    Auger, Danielle
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2009, 13 (02) : 177 - 180
  • [3] Population Pharmacokinetics of High-Dose Methotrexate in Patients With Primary Central Nervous System Lymphoma
    Mei, Shenghui
    Li, Xingang
    Jiang, Xueyun
    Yu, Kefu
    Lin, Song
    Zhao, Zhigang
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 107 (05) : 1454 - 1460
  • [4] High-dose methotrexate toxicity in elderly patients with primary central nervous system lymphoma
    Jahnke, K
    Korfel, A
    Martus, P
    Weller, M
    Herrlinger, U
    Schmittel, A
    Fischer, L
    Thiel, E
    ANNALS OF ONCOLOGY, 2005, 16 (03) : 445 - 449
  • [5] High-dose methotrexate dosing strategy in primary central nervous system lymphoma
    Wang, Alexander
    Cirrone, Frank
    De los Reyes, Francis Andrew
    Papadopoulos, John
    Saint Fleur-Lominy, Shella
    Xiang, Elaine
    LEUKEMIA & LYMPHOMA, 2022, 63 (06) : 1348 - 1355
  • [6] Hepatotoxicity from high-dose methotrexate in primary central nervous system lymphoma
    Zhang, Joy C.
    Stotts, Matthew J.
    Horton, Bethany
    Schiff, David
    NEURO-ONCOLOGY PRACTICE, 2023, 10 (03) : 291 - 300
  • [7] HEPATOTOXICITY FROM HIGH-DOSE METHOTREXATE IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
    Zhang, Joy C.
    Horton, Bethany J.
    Stotts, Matthew J.
    Schiff, David
    GASTROENTEROLOGY, 2022, 162 (07) : S1284 - S1285
  • [8] White matter changes in primary central nervous system lymphoma patients treated with high-dose methotrexate with or without rituximab
    Fayez Estephan
    Xiaobu Ye
    Omar Dzaye
    Nina Wagner-Johnston
    Lode Swinnen
    Douglas E. Gladstone
    Rich Ambinder
    David Olayinka Kamson
    Sebastian Lambrecht
    Stuart A. Grossman
    Doris D. M. Lin
    Matthias Holdhoff
    Journal of Neuro-Oncology, 2019, 145 : 461 - 466
  • [9] White matter changes in primary central nervous system lymphoma patients treated with high-dose methotrexate with or without rituximab
    Estephan, Fayez
    Ye, Xiaobu
    Grossman, Stuart A.
    Lin, Doris D.
    Holdhoff, Matthias
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [10] HIGH-DOSE METHOTREXATE, HIGH-DOSE CYTARABINE AND TEMOZOLOMIDE FOR THE TREATMENT OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
    Salamoon, M.
    Hussein, T.
    Kenj, M.
    HAEMATOLOGICA, 2013, 98 : 355 - 355
12345